Arimidex is a brand-name medication that contains anastrozole as its active component. Anastrozole belongs to the class of drugs known as aromatase inhibitors and is primarily used in women’s health to support oncology treatment, especially for hormone-receptor-positive breast cancer in post-menopausal patients. In Hong Kong, Arimidex is a prescription-only product regulated by the Department of Health’s Pharmacy and Poisons Board.
Anastrozole blocks the enzyme aromatase, which converts androgens (male hormones) into estrogen. By inhibiting this conversion, Arimidex markedly reduces circulating estrogen levels. Lower estrogen deprives hormone-sensitive breast cancer cells of the growth signal they need, slowing tumor progression and reducing the chance of recurrence.
Key pharmacologic points:
Arimidex is approved in Hong Kong (and internationally) for the following indications:
These uses are based on extensive clinical trial data showing improved disease-free survival when an aromatase inhibitor is incorporated into standard treatment protocols.
Some clinicians consider off-label applications of anastrozole, supported by limited research:
Disclaimer: Off-label use is not approved by the Hong Kong Department of Health. Such use must be supervised by a qualified healthcare professional, with individualized risk assessment.
These effects are usually transient and can be managed with lifestyle adjustments or supportive medications as advised by a healthcare provider.
Dosing adjustments for hepatic impairment, extreme age, or renal dysfunction should be made by the treating oncologist or pharmacist.
Regular follow-up appointments allow the care team to adjust therapy, manage side effects, and ensure optimal cancer control.
This article provides educational information about Arimidex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Arimidex (anastrozole) is a non-steroidal aromatase inhibitor taken once daily at a fixed 1 mg dose. Other agents, such as letrozole and exemestane, have different dosing schedules and half-life profiles. Clinical choice depends on individual patient factors, side-effect tolerability, and physician preference.
Mild hepatic impairment generally does not require dose modification, but severe liver dysfunction may necessitate a lower dose or alternative therapy. Liver function should be monitored regularly.
No. Arimidex dramatically lowers estrogen, which is essential for fetal development. Effective contraception is required during treatment and for at least two months after the last dose.
Standard adjuvant therapy lasts 5 years, but the exact duration may be individualized based on tumor characteristics and ongoing risk assessment.
Some studies suggest modest changes in lipid profiles, but the clinical impact is generally small. Routine cholesterol monitoring is advisable, especially in patients with pre-existing dyslipidemia.
Yes, calcium and vitamin D are often recommended to help mitigate bone loss associated with estrogen suppression. Discuss appropriate dosages with your healthcare provider.
Baseline labs, including liver function tests and a bone density scan, are standard before initiating therapy to assess suitability and to establish monitoring parameters.
Older patients are not automatically given a lower dose, but clinicians may monitor more closely for side effects such as fractures or liver changes and adjust treatment if necessary.
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of the destination country’s regulations regarding prescription drugs.
Report the symptom to your oncologist; they may suggest analgesics, physical therapy, or a brief drug holiday, depending on the severity and impact on quality of life.
